Skip Navigation

ENCERT: A Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Relapsed T Cell Lymphoblastic Leukemia/Lymphoma

Brief Summary


Study Type:

I Identifier:

Study #:
CMH - AflacLL1602

Start Date:
Jan 31, 2019

Full Details and Eligibility at

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below. ID: NCT03328104

View Complete Trial Details & Eligibility at